← Back
Data updated: Mar 10, 2026
CELERITY PHARMS
Pharmaceuticals
CELERITY PHARMS is a pharmaceutical company with 1 FDA-approved products.
-
Since
1
Drugs
-
Trials
2
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
BENDAMUSTINE HYDROCHLORIDE 2025-07-03
Type 5 - New Formulation or New Manufacturer
BENDAMUSTINE HYDROCHLORIDE 2024-04-15
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (0)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 1